Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 18,750 | 16,705 | 14,297 | 9,133 | 7,156 |
| Cost of Goods | 6,970 | 6,263 | 5,324 | 2,227 | 1,647 |
| Gross Profit | 11,780 | 10,443 | 8,973 | 6,906 | 5,509 |
| Operating Expenses | 19,749 | 17,292 | 19,317 | 18,561 | 19,439 |
| Operating Income | -7,000 | -6,587 | -10,020 | -11,428 | -13,283 |
| Interest Expense | 0 | 0 | 0 | 0 | 25 |
| Other Income | 412 | 172 | 183 | 216 | 167 |
| Pre-tax Income | -6,588 | -6,416 | -9,837 | -11,212 | -13,141 |
| Net Income Continuous | -6,588 | -6,416 | -9,837 | -11,212 | -13,141 |
| Net Income | $-6,588 | $-6,416 | $-9,837 | $-11,212 | $-13,141 |
| EPS Basic Total Ops | -0.14 | -0.16 | -0.23 | -0.29 | -0.37 |
| EPS Basic Continuous Ops | -0.14 | -0.16 | -0.24 | -0.29 | -0.37 |
| EPS Diluted Total Ops | -0.14 | -0.16 | -0.23 | -0.29 | -0.37 |
| EPS Diluted Continuous Ops | -0.14 | -0.16 | -0.24 | -0.29 | -0.37 |
| EBITDA(a) | $-6,624 | $-6,471 | $-9,808 | $-11,283 | $-14,135 |